KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $76,000 | +181.5% | 421 | +58.9% | 0.00% | – |
| Q2 2017 | $27,000 | -43.8% | 265 | -55.8% | 0.00% | – |
| Q1 2017 | $48,000 | +500.0% | 600 | +200.0% | 0.00% | – |
| Q4 2016 | $8,000 | -86.2% | 200 | -81.0% | 0.00% | – |
| Q3 2016 | $58,000 | +100.0% | 1,050 | +82.3% | 0.00% | – |
| Q2 2016 | $29,000 | +20.8% | 576 | +8.1% | 0.00% | – |
| Q1 2016 | $24,000 | -41.5% | 533 | -21.3% | 0.00% | – |
| Q4 2015 | $41,000 | +17.1% | 677 | +7.8% | 0.00% | – |
| Q3 2015 | $35,000 | +34.6% | 628 | +45.0% | 0.00% | – |
| Q2 2015 | $26,000 | -88.8% | 433 | -89.3% | 0.00% | – |
| Q1 2015 | $232,000 | +2800.0% | 4,037 | +2846.7% | 0.00% | – |
| Q4 2014 | $8,000 | – | 137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $185,086,000 | 58.62% |
| BAINCO INTERNATIONAL INVESTORS | 879,840 | $69,059,000 | 9.77% |
| Coastal Bridge Advisors, LLC | 235,140 | $18,456,000 | 6.29% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,433,899 | $112,547,000 | 5.71% |
| NEXTHERA CAPITAL LP | 105,000 | $8,241,000 | 4.20% |
| ARK Investment Management | 87,364 | $6,857,000 | 1.98% |
| Casdin Capital, LLC | 42,500 | $3,336,000 | 1.97% |
| BB BIOTECH AG | 740,000 | $58,083,000 | 1.90% |
| FT Options LLC | 81,700 | $1,287,000 | 1.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 55,500 | $4,346,000 | 1.66% |